Tauranga Urology Research

Tauranga Urology Research is a New Zealand urology-focused clinical research company affiliated with the Tauranga urology practice Urology Bay of Plenty. The company conducts Phase 1, 2, and 3 clinical trials spanning both medical devices and pharmaceuticals, with a particular emphasis on urologic conditions. Its work has included participation in first-in-human and other early clinical studies related to benign prostatic hyperplasia treatments such as HoLEP and Aquablation, as well as studies in advanced prostate cancer, bladder cancer, post-prostatectomy stress incontinence, and overactive bladder. The organization appears to function primarily as a specialist clinical trial site and investigator-led research vehicle rather than as a therapeutic product developer with an internal proprietary pipeline.